Antiviral pyrazolopyridine compounds

Hirohito Katayama, Takafumi Mitsunaga, Atsushi Akahane, Youichi Shiokawa, Pyrazolopyridine compounds which have useful pharmaceutical utility ,(1992)

Robert W. Ward, Roger E. Markwell, Pyrazolopyridine derivatives useful in treating inflammation and allergic conditions ,(1986)

Serge Mignani, Conception Nemecek, Jean-Christophe Carry, Pyrrole derivatives, their preparation and pharmaceutical compositions containing them ,(1997)

Ian Baxter Campbell, Alan Naylor, Paul John Beswick, IMIDAZO[1,2-a]PYRIDINE DERIVATIVES ,(1996)

Gary D Anderson, Susan A Gregory, Peter C Isakson, Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor ,(1996)

Alan Glaxo Wellcome plc Naylor, Ian Baxter Glaxo Wellcome plc Campbell, Pyrazolopyridine derivatives as selective cox-2 inhibitors ,(1999)

Tesfaye Biftu, Richard Beresis, Dennis M. Schmatz, Xiaoxia Qian, James B. Doherty, Charles J. Mcintyre, Dennis D. Feng, Gui-Bai Liang, David A. Claremon, Richard Berger, Steven L. Colletti, Ernest W. Kovacs, Nigel J. Liverton, Pyrimidinyl) (phenyl) substituted fused heteroaryl p38 inhibiting and PKG kinase inhibiting compounds ,(2002)

Andrew Peter Thomas, Pyrimidine derivatives for inhibition of cell-proliferation ,(2002)

Carl Perchonock, Paul Elliot Bender, Jerry Leroy Adams, Anthony John Villani, Timothy Francis Gallagher, John Richard Heys, Inhibition of 5-lipoxygenase and cyclooxygenase pathway mediated diseases ,(1991)

Michel Therien, Serge Leger, Petpiboon Prasit, Daniel Guay, Zhaoyin Wang, Diaryl bicyclic heterocycles as inhibitors of cyclooxygenase-2 ,(1995)